<--- Back to Details
First PageDocument Content
Interferon / Pharmaceutical drug / Boceprevir / Approval voting / Protease inhibitors / Pyrazines / Telaprevir
Date: 2014-09-05 18:53:58
Interferon
Pharmaceutical drug
Boceprevir
Approval voting
Protease inhibitors
Pyrazines
Telaprevir

Kentucky Department for Medicaid Services

Add to Reading List

Source URL: www.chfs.ky.gov

Download Document from Source Website

File Size: 206,39 KB

Share Document on Facebook

Similar Documents

IP followed by western blot Every step needs to be performed cold, either in the cold room or on ice!!! • Lyse cells in appropriate lysis buffer (standard buffer is 1% NP40 or Triton-X100) with protease inhibitors

DocID: 1szfy - View Document

Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). Ada

DocID: 1sgtI - View Document

Microbiology / HIV/AIDS / Virology / Integrase / HIV / Nef / Management of HIV/AIDS / Zidovudine / Retrovirus / Discovery and development of integrase inhibitors / Discovery and development of HIV-protease inhibitors

June 17, 2009  Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

DocID: 1qLnJ - View Document

HIV/AIDS / Protease inhibitors / HIV / Lentiviruses / Reverse-transcriptase inhibitor / Carbamates / Tuberculosis management

Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). Ada

DocID: 1pbRe - View Document

Medicinal chemistry / Metabolism / Fatty acid amide hydrolase / Enzyme inhibitor / Chemical biology / Benjamin Cravatt III / Substrate / Acetylcholinesterase / Protease inhibitor / Activity-based proteomics / Methoxy arachidonyl fluorophosphonate

© 2003 Nature Publishing Group http://www.nature.com/naturebiotechnology LETTERS Discovering potent and selective reversible inhibitors of enzymes in complex proteomes

DocID: 1oHMR - View Document